Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statins and bone formation.

I R Garrett1, G Gutierrez, G R Mundy

  • 1Department of Endocrinology/Medicine, University of Texas Health Science Center at San Antonio, USA. rossos@aol.com

Current Pharmaceutical Design
|June 19, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unveiling balanced prenatal microbial colonization in amniotic fluid through an integrated culture and sequencing approach.

Journal of translational medicine·2026
Same author

ASO Visual Abstract: Targeted Preoperative Nutritional Support Within an Enhanced Recovery After Surgery Program for Malnourished Colorectal Cancer Patients: Postoperative Outcomes Comparable to Well-Nourished Patients in a Prospective Single-Center COHORT.

Annals of surgical oncology·2025
Same author

Genomic scan of selective sweeps in an alpaca population subjected to directional selection for fibre quality traits.

Animal : an international journal of animal bioscience·2025
Same author

Positive Neutrino Masses with DESI DR2 via Matter Conversion to Dark Energy.

Physical review letters·2025
Same author

Retraction Note: Burnout components, perceived stress and hair cortisol in healthcare professionals during the second wave of COVID 19 pandemic.

Scientific reports·2025
Same author

Corrigendum to "Synthesis of controlled size starch nanoparticles (SNPs) title of article" [Carbohydr. Polym. 250 (2020) 116938].

Carbohydrate polymers·2025
Same journal

Role of Phenolic Nanocompounds in Inflammatory Disorders: Current View and Future Aspects.

Current pharmaceutical design·2026
Same journal

Overcoming Physiological Barriers in Brain Tumor Therapy: Advances in Nanomedicine, Ultramolecular Pharmaceuticals, and Targeted Drug Delivery.

Current pharmaceutical design·2026
Same journal

Breathing Life into Research: The Transformative Potential of Lung-on-a-Chip Technology.

Current pharmaceutical design·2026
Same journal

Cross-Tissue Transcriptome-Wide Association Study Prioritizes Candidate Genes and Compound-Associated Signatures for Osteoarthritis.

Current pharmaceutical design·2026
Same journal

Emerging Role of AI in Gastroenterology and Hepatology: Revolutionizing Medical Device-Assisted Diagnosis.

Current pharmaceutical design·2026
Same journal

Nanostructured Lipid Carriers in Drug Targeting: Characterization, Patents, and Recent Innovations.

Current pharmaceutical design·2026
See all related articles

Statins, commonly used for cholesterol reduction, show potential as anabolic agents for osteoporosis treatment by stimulating new bone formation. Further clinical trials are needed to confirm their efficacy in fracture risk reduction.

Area of Science:

  • Bone biology and pharmacology
  • Metabolic disease treatment

Background:

  • Osteoporosis treatment primarily focuses on inhibiting bone resorption, leaving a need for anabolic agents to stimulate bone formation.
  • Current osteoporosis therapies stabilize bone mass but do not fully correct structural deficits in established disease.

Purpose of the Study:

  • To explore the potential of statins as anabolic agents for osteoporosis treatment.
  • To investigate the mechanism by which statins stimulate bone formation.

Main Methods:

  • Review of existing research on statins and bone metabolism.
  • Analysis of in vitro and in vivo studies in rodents demonstrating statin-induced bone formation.
  • Examination of clinical data suggesting statins may reduce fracture risk.

Related Experiment Videos

Main Results:

  • Statins, inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, stimulate bone formation and increase bone mass in rodents.
  • This effect is linked to increased bone morphogenetic protein-2 (BMP-2) gene expression in bone cells.
  • Clinical data indicates statins may reduce fracture risk, though further research is required.

Conclusions:

  • Statins exhibit pleiotropic effects beyond cholesterol reduction, including potential anabolic activity in bone.
  • Their ability to stimulate bone formation suggests a promising therapeutic avenue for osteoporosis.
  • Randomized clinical trials are essential to establish the efficacy of statins in treating osteoporosis and reducing fracture risk.